GlassScriptPhysician profile
Julia Delcour
NPI 1336457423
$3,280.99
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,506 · 2022: $775.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $883.97 | 2021-2022 | |
| Glaxosmithkline, LLC. | $508.44 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.98 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $226.18 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $225.20 | 2021 | |
| Genzyme Corporation | $188.62 | 2021-2022 | |
| Amgen INC. | $135.38 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.73 | 2021 | |
| Grifols USA, LLC | $118.71 | 2021-2022 | |
| Optinose US, INC. | $102.52 | 2021-2022 | |
| Pfizer INC. | $81.60 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $59.61 | 2021-2022 | |
| Biocryst US Sales Co., LLC | $57.16 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $49.37 | 2021 | |
| Incyte Corporation | $46.36 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $42.05 | 2022 | |
| Alk-Abello, INC | $41.73 | 2021-2022 | |
| Philips North America LLC | $25.07 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.69 | 2022 | |
| Csl Behring | $13.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.11 | 2022 | |
| Genentech USA, INC. | $11.89 | 2021 | |
| Merck Sharp & Dohme LLC | $11.65 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Delcour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.